⌘K

Login Start Free

Home/Filings/4/0001209191-12-014902

4//SEC Filing

Standring David 4

Accession 0001209191-12-014902

CIK 0001093649other

View on SEC.gov Company Profile

Filed

Mar 1, 7:00 PM ET

Accepted

Mar 2, 1:45 PM ET

Size

5.5 KB

Accession

0001209191-12-014902

Insider Transaction Report

Form 4

Period: 2012-02-29

IDENIX PHARMACEUTICALS INCIDIX

Standring David

EVP, Biology

Transactions

Award
Employee Stock Option (Right to Buy)
2012-02-29+125,000→ 125,000 total
Exercise: $12.08Exp: 2022-02-28→ Common Stock (125,000 underlying)

Footnotes (1)

[F1]This option vests in 48 equal monthly installments beginning on February 29, 2012 and continuing thereafter on the last day of each of the next succeeding 47 months.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

IDENIX PHARMACEUTICALS INC

CIK 0001093649

Entity typeother

Related Parties

1

filerCIK 0001428085

Filing Metadata

Form type: 4
Filed: Mar 1, 7:00 PM ET
Accepted: Mar 2, 1:45 PM ET
Size: 5.5 KB

View on SEC.gov